RAFSYGA Trademark
Trademark Overview
On Tuesday, November 11, 2014, a trademark application was filed for RAFSYGA with the United States Patent and Trademark Office. The USPTO has given the RAFSYGA trademark a serial number of 79157848. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, November 11, 2024. This trademark is owned by NOVARTIS AG. The RAFSYGA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, and diabetes; antifungal, anti...
General Information
| Serial Number | 79157848 |
| Word Mark | RAFSYGA |
| Filing Date | Tuesday, November 11, 2014 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Monday, November 11, 2024 |
| Registration Number | 4745806 |
| Registration Date | Tuesday, June 2, 2015 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 17, 2015 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, and diabetes; antifungal, anti-infective, and antiviral preparations and antibiotics |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | H - NOT AVAILABLE |
| Class Status Date | Thursday, July 5, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | NOVARTIS AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Friday, January 2, 2015 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, January 6, 2015 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Wednesday, January 7, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 13, 2015 | APPLICATION FILING RECEIPT MAILED |
| Monday, February 2, 2015 | ASSIGNED TO EXAMINER |
| Friday, February 6, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 25, 2015 | NOTICE OF PUBLICATION |
| Tuesday, March 17, 2015 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 2, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, July 2, 2015 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Friday, July 31, 2015 | FINAL DISPOSITION PROCESSED |
| Friday, August 21, 2015 | NOTIFICATION PROCESSED BY IB |
| Friday, July 20, 2018 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Friday, July 26, 2019 | NOTIFICATION PROCESSED BY IB |
| Monday, June 9, 2025 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, July 20, 2018 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, July 31, 2015 | FINAL DISPOSITION NOTICE SENT TO IB |
